Skip to main content

Cytosorbents Corp

corporate_fare Company Profile

Cytosorbents Corp

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed CTSO - Latest Insights

CTSO
Apr 15, 2026, 5:18 PM EDT
Filing Type: 10-K/A
Importance Score:
7
Cytosorbents Discloses Deferred Executive Bonuses Due to Insufficient Liquidity
Sentiment: Negative
View Wiseek Article
CTSO
Apr 02, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Nasdaq Grants CytoSorbents 180-Day Extension to Regain Minimum Bid Price Compliance
Sentiment: Negative
View Wiseek Article
CTSO
Mar 30, 2026, 7:04 AM EDT
Filing Type: 10-K
Importance Score:
9
Auditor Issues Going Concern Warning; Company Faces Nasdaq Delisting Risk and Regulatory Setbacks for Key Product
Sentiment: Negative
View Wiseek Article
CTSO
Mar 25, 2026, 4:27 PM EDT
Filing Type: 8-K
Importance Score:
7
CytoSorbents Reports Improved 2025 Financials, Targets H2 2026 Cash Flow Breakeven
Sentiment: Neutral
View Wiseek Article
CTSO
Mar 25, 2026, 4:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CytoSorbents Narrows Full-Year Loss to $0.13/Share, Advances Key FDA Discussions
Sentiment: Neutral
View Wiseek Article